𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trial designs used to study neuroprotective therapy in Parkinson's disease

✍ Scribed by Anthony E. Lang; Eldad Melamed; Werner Poewe; Olivier Rascol

Book ID
115559983
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
163 KB
Volume
28
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Are delayed-start design trials to show
Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
✍ Carl E. Clarke πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

## Abstract Considerable effort has gone into preclinical neuroprotection research in Parkinson's disease (PD) and several large clinical trials have been mounted, but no agent has been conclusively shown to be protective. The latest innovation in PD neuroprotection trial design is the delayed‐star

Neuroprotection trials in Parkinson's di
Neuroprotection trials in Parkinson's disease: Systematic review
✍ Robert G. Hart; Lesly A. Pearce; Bernard M. Ravina; Toby C. Yaltho; John R. Marl πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr